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Abstract: 
Background: Symptomatic chronic subdural hematoma (scSDH) is one of the most 
frequent diseases in neurosurgical practise with an increasing incidence. However 
treatment modalities are still controversial. 
Objective: The aim of this retrospective single centre study is to compare for the first 
time two surgical methods in the treatment of subdural hematoma, which have been 
proven to be efficient in previous studies, in a direct comparison. 
Methods: We analyzed the data of 143 scSDH in 113 patients undergoing surgery for 
subdural hematoma with placement of subperiostal or subdural drainage after double 
burr hole trepanation for hematoma evacuation. 
Results: Overall there were no statistically significant differences regarding general 
patient characteristics, preoperative and postoperative symptoms, postoperative 
hematoma remnant, rates of recurrences, mortality, complications and outcome at 
discharge and at three month follow up between the groups. There was a close to 
significant tendency of lower mortality after placement of subperiostal drainage 
system and a tendency towards lower rate of recurrent hematoma after placement of 
subdural drainage system. 
Conclusions: Our study shows for the first time a direct comparison of two mainly 
used surgical techniques in scSDH treatment. Both methods proved to be highly 
effective and general patient data, complications, outcome and mortality of both 
groups are equal or superior compared to previously published series. As there is a 
clear tendency to less mortality and less serious complications the treatment with 
double burr hole trepanation, irrigation and placement of subperiostal drainage is our 
treatment of choice in patients with predictable high risk of complications. 
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Introduction: 
Symptomatic chronic subdural hematoma (scSDH) was first described by Virchow in 
1857 as “pachymeningitis haemorrhagica interna” and is nowadays one of the most 
frequent diagnosis in neurosurgical practice [3,5,18]. Incidence is reported to be 
between 1.7 and 13.1 per 100.000 inhabitants per year [3,5] and as scSDH  is mainly 
found in elderly patients there has been a  steady increasing incidence due to 
prolonged life expectancy in developing countries in recent years [1,5]. Therapeutic 
options include non-surgical or surgical management by means of craniotomy, burr 
hole trepanation or twist drill craniostomy. In general, surgical treatment is 
recommended in case of neurological symptoms [1,2,5,7,9-13,17,19,20]. In those 
cases double burr hole trepanation is the surgical method of choice as studies 
showed the best outcome in patients treated with double burr hole trepanation 
combined with irrigation and placement of a closed drainage system at first diagnosis 
of scSDH [8,19]. Furthermore, a recent prospective study showed that the use of a 
subdural drain after burr-hole trepanation is safe and associated with reduced 
recurrence and mortality [14]. 
Nevertheless, up to now there are only few class (II) evidence and no class (I) 
evidence publications in the literature on the treatment of scSDH. 
Recent development in surgical treatment of scSDH includes a study of Zumofen et 
al analyzing a closed subperiostal drainage system instead of the commonly used 
subdural drainage system [20]. Remarkably their results regarding outcome, 
complications and postoperative symptoms were equal or superior to previously 
published studies5. Moreover a drainage system, which is not positioned in direct 
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contact to cortical structures, bridging veins or hematoma membranes seems to 
prevent more likely postoperative seizures and severe complications [20]. However 
there is no comparative study that evaluates that evaluates the advantages of the 
subperiostal drainage placement compared to subdural drainage placement. The 
present study compares for the first time the technique of subperiostal drainage with 
the more commonly used method of subdural drainage in a single-centre study 
including the same surgeons and the same pre-, peri- and postoperative 
mamagement for both study groups. 
 
Clinical material and methods 
General patient data: 
In a retrospective study we reviewed the data of 113 patients who underwent surgery 
for symptomatic chronic subdural hematomas from 2007 to 2009 at the Department 
of Neurosurgery, University Hospital Zurich. Inclusion criteria consisted of patients 
receiving double burr hole trepanation, intraoperative irrigation and placement of 
subdural or subperiostal closed drainage system as the first surgical treatment. A 
total number of 113 patients receiving surgery for 143 symptomatic chronic subdural 
hematoma were included and analyzed. The patients were divided into two groups 
according to the drainage system used intraoperatively. General patient data 
including age, sex, secondary diagnosis, medication and other risk factors as well as 
preoperative symptoms, Glasgow Coma Scale (GCS) at admission and findings of 
preoperative computed tomography studies (CT) were collected. Operation type 
(subdural drainage vs. subperiostal drainage, one side vs. two sides), postoperative 
symptoms, time and findings of postoperative CT scan, complications, rate of 
recurrence- or remnant hematoma, rate of mortality, duration of hospitalization and 
Glasgow Outcome Scale (GOS) [7] were noted as well. At the time of follow up 
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remaining neurological symptoms, CT findings, rate of reoperation, mortality and 
Glasgow Outcome Scale (GOS) were analyzed. 
 
Surgery and postoperative treatment: 
All patients included in this study underwent first time surgery for a first time 
diagnosed symptomatic chronic subdural hematoma after written informed consent 
and received double burr hole trepanation, intraoperativ irrigation with body 
temperature saline and intraoperative placement of a subdural or subperiostal closed 
drainage system. Antiplatelet and anticoagulation medication was stopped before 
surgery and application of Beriplex™ (CSL Behring, USA) or vitamin k (Konakion™, 
Roche, Basel, Switzerland) was administered if needed to establish normal clotting 
parameters. Antiepileptic medication was given only in patients presenting with 
seizures before admission. In all cases surgery was performed during general 
anaesthesia and patients were placed in supine position with the head on a plastic 
ring without Mayfield fixation. A single shot antibiotic prophylaxis with 1g Cefazoline 
(Kefzol™, TEVA Pharmaceutical Industries Ltd., Tel Aviv, Israel) was given to all 
patients directly before skin incision. In all cases, skin incisions and burr holes were 
placed above the superior temporal line and dura mater was opened and coagulated. 
Subdural irrigation was performed with body tempered saline solution. After 
evacuation of the hematoma a drainage system was inserted. Whether to place a 
subdural or a subperiostal drainage system was decided by the surgeon during 
surgical planning. In case of placement of a subperiostal drainage system a redon 
drain Ch10 (B.Braun Medical AG, Melsungen, Germany) was inserted subperiostally 
and placed with its holes across the two burr holes (Figure 01). In case of placement 
of a subdural drainage system a nelaton bladder catheter Ch10 (Rüsch, Kernen i.R., 
Germany) was inserted through the posterior burr hole and gently pushed forward in 
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the subdural space (Figure 02). Either drain was then pulled through a small skin 
incision posterior to the posterior burr hole and connected to a urine collecting bag 
with non return valve and drainage device (Dahlhausen, Cologne, Germany). The 
drainage system was placed just below head level. The posterior skin incisions were 
closed first and then the subdural space was filled with body tempered saline before 
closing the anterior skin incisions to minimize intracranial air collections. 
Postoperatively, the patients were transferred to an intermediate or intensive care 
unit for postoperative observation for 6 to 24 hours. Afterwards they were transferred 
to the general ward. Low dose heparin prophylaxis was given in all cases starting 
within the first 48 hours after surgery as well as compression boots. Postoperative CT 
scan was performed within the first 24 hours after surgery. The findings on CT 
(hematoma size, maximum thickness of the hematoma, midline shift, secondary 
neuroradiological diagnosis) were measured and complications recorded. Forty-eight 
hours after surgery the drainage system was removed and thereafter the patients 
were mobilized. Approximately one week after surgery, patients were discharged, 
transferred to rehabilitation clinics in cases of persisting severe neurological deficits 
or regional hospitals in case of need for further - not hematoma related - medical 
treatment. 
 
Follow-up: 
Three month after surgery patients were seen again at the outpatient department. 
Persisting neurological deficits, general condition and GOS were examined. Follow-
up CT scan was performed in all patients and neuroradiological findings (hematoma 
size, midline shift, secondary diagnosis, subdural fluid collections) were analyzed. 
 
Statistical analysis and neuroimaging: 
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The statistical analysis was performed using Microsoft Excel and SPSS Statistic 
software. The correlation of the investigated parameters was statistically analyzed 
by using Student’s t-Test, Fisher’s exact test and chi-quare test. Statistical 
significance was assumed at a level of p<0.01. 
All CT scans were performed on a 16 slice Siemens SOMATON® Sensation 
acquiring non contrast-enhanced 4mm axial slices. The CT scans were analyzed 
independently and blinded to the clinical outcome using standardized software 
(picture archiving and communication system, PACS). Hematoma size, maximum 
hematoma width, hematoma remnant/-recurrence, midlineshift, hygroma formation 
and secondary neuroradiological diagnosis were noted. Hematoma remnant/-
recurrence were noted in case of hyperdens structures bigger than 1ccm in size. We 
differentiated between subdural irrigation fluid, hematoma remnant/-recurrence and 
subdural hygroma formation. 
 
 
Results: 
Study and general patients characteristics: 
One hundred thirteen patients underwent surgery for 143 symptomatic chronic 
subdural hematomas (scSDH) (Table 01). Forty-eight patients received treatment 
with subperiostal drainage (spd) for 21 left sided, 20 right sided and 7 bilateral cSDH. 
Sixty five patients received treatment with subdural drainage (sdd) for 14 left sided, 
28 right sided and 23 bilateral cSDH. There were 32 male patients (66.7%) in the 
group treated with spd and 45 male patients (69.2%) in the group treated with sdd. 
The mean age was 77 years in the spd group and 71 years in the sdd group (p = 
0.015). In the spd group there were 11 patients (22.9%) on oral anticoagulation and 
17 patients (35.4%) on antiplatelet medication. In the sdd group there were 18 
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patients (27.7%) on oral anticoagulation and 16 patients (24.6%) on antiplatelet 
medication. The most frequent secondary diagnoses were hypertension (47.9% 
subperiostal drain group / 44.6% subdural drain group), diabetes type II (8.3% / 
6.1%), cardiac arrhythmia (16.7% / 15.4%), coronary disease (14.6% / 20.0%), 
COPD (4.2% / 6.1%), chronic renal disease (14.6% / 13.8%), malignant tumor 
(18.7% / 13.8%) and history of stroke (12.5% / 10.7%). There were no statistically 
significant differences regarding these parameters between the two groups (range of 
p-values: 0.021-1.000). 
 
Peri-/postoperative complications: 
Complications were divided into surgery related complications such as clinical 
significant hematoma remnant or recurrence and intracerebral hematoma and other 
complications such as urinary tract infection, pneumonia and thrombosis (Table 02).  
In the spd group surgical complications occurred in 8.3% of patients or 7.3% of 
hematomas. There was a clinical significant hematoma remnant in 6.2% of patients 
or 5.4% of hematomas. There was a hematoma recurrence during hospitalization in 
1.8% of patients or 1.5% of hematomas. No case of postoperative intraparenchymal 
hematoma was found. Those complications led to four reoperations. In three cases 
hematoma re-evacuation was performed using the existing burr hole craniotomies 
and in one case craniotomy was done to evacuate the recurrent hematoma.  
In the sdd group there was an overall surgical complication rate of 10.3% of the 
patients or 7.9% of hematomas. There was a clinical significant hematoma remnant 
in 1.5% of patients or 1.1% of hematomas. There was hematoma recurrence in 3.1% 
of patients or 2.3% of hematomas and there were postoperative intraparenchymal 
hematomas in 6.1% of patients or 4.5% of hematomas.  
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There were no statistically significant differences between the two groups regarding 
those complications (range of p-values: 0.135-1.000). Regarding non surgical 
complications there were urinary tract infections in 25.0% of the patients in the spd 
group and in 21.5% of the patients in the sdd group. Pneumonia was found in 6.2% 
of the patient in the spd group and 13.8% of patients in the sdd group. Other non 
surgical complications were present in 12.5% of the patients in the spd group and 
13.8% of the patients in the sdd group. There was no statistically significant 
difference between the two groups (range of p-values: 0.231-0.920). There was no 
case of wound infection in both groups. There was one case of mortality during 
hospitalization in the sdd group (due to a postoperative intraparenchymal hematoma) 
but none in the spd group. 
 
Hematoma size and neuroradiological findings: 
All patients underwent preoperative and postoperative CT scan (Table 03). Nearly all 
patients, 95.8% in the spd group and 95.4% in the sdd group within the first 24 hours 
after surgery. All patients seen for follow-up examination three month after surgery 
underwent another CT scan. There were no differences in mean hematoma size, 
mean midline shift and mean coronar width of hematoma between the two groups 
(range of p-values: 0.176-0.857) at preoperative-, postoperative- or follow up CT 
scan. Postoperatively there was a significant drop in coronar hematoma width 
compared to the preoperative imaging studies in both groups (p<0.001). In the group 
with spd the mean coronar width was 20.37mm in the preoperative, 5.75mm in the 
postoperative and 1.55mm in the follow up CT scan at three month after surgery. In 
the group with sdd the mean preoperative hematoma width was 19.51mm, 5.75mm in 
the postoperative imaging and 0.93mm at follow up. 
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The mean hematoma volume dropped postoperative significantly in both groups. In 
the group with subperiostal drainage from 119*103mm3 to 8*103mm3 (p<0.001) and in 
the group with subdural drainage from 108*103mm3 to 8*103mm3 (p<0.001). There 
was another but not significant drop in mean hematoma size in the group with spd 
from 8*103mm3 to 6*103mm3 (p=0.448) and a significant drop in the group with sdd 
from 8*103mm3 to 2*103mm3 (p<0.001) between the postoperative CT scan and the 
CT scan at follow up. 
 
Preoperative symptoms: (Table 04a): 
The most frequent preoperative symptoms included paresis (52.1% spd group / 
52.3% sdd group), aphasia (22.9% / 32.3%), headache (62.5% / 67.7%), imbalance 
(81.3% / 50.8%), epileptic seizures (12.5% / 6.2%) and acute state of confusion 
(58.3% / 47.7%). There was a significant higher percentage of patients with 
imbalance in the group with spd (p<0.001) but no other statistically significant 
difference between the two groups regarding the preoperative symptoms (range of p-
values: 0.319-0.862). The mean GCS at admission was 14.2 in both groups 
(p=0.920). 
 
Postoperative symptoms and outcome (Table 04b): 
Patients were examined again after surgery regarding the preoperative symptoms. 
There was a drop of the frequency of nearly all preoperative symptoms in both 
groups. Frequency of paresis (52.1% to 10.4% spd group / 52.3% to 13.8% sdd 
group), aphasia (22.9% to 4.2%/ 32.3% to 10.8%), headache (62.5% to 12.5%/ 
67.7% to 23.1%), imbalance (81.3% to 43.8%/ 50.8% to 24.6%), epileptic seizures 
(12.5% to 2.1%/ 6.2% to 6.2%) and acute state of confusion (58.3% to 18.8%/ 47.7% 
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to 15.4%). Except for epileptic seizures patients in both groups had statistically 
significant less symptoms postoperative (p<0.001).  
The mean hospitalization time was 9.6 days in the spd group and 9.1 days in the sdd 
group (p=0.818). The mean GOS at discharge was 4.3 in the spd group and 4.2 in 
the sdd group (p=0.772). 
 
Symptoms at follow up and long-term outcome (Table 04c): 
Follow up was scheduled for three months after surgery. The patients were seen 
after an average time of 68 days in the spd group and after 90 days in the sdd group 
(p=0.022). There was a loss to follow up of 16.6% of patients in the spd group and 
21.5% in the sdd group (p=0.689). The mean GOS was 4.8 in both groups (p=0.597) 
and there was a persisting minor hematoma in 22.2% in the spd group and 19.6% in 
the sdd group (p=0.920). The rate of persisting hematoma related symptoms was 
16.7% in the spd group and 17.6% in the sdd group (p=0.920). There was additional 
surgery for remnant or recurrence hematoma in 20.0% of the spd patients and 6.8% 
of the sdd patients within the first year after primary surgery. The overall mortality 
rate within the first year after primary surgery was 2.1% in the spd group and 10.7% 
in the sdd group (p=0.135).  
 
Discussion: 
Symptomatic chronic subdural hematoma is one of the most frequent diagnosis in 
neurosurgical practise mainly found in elderly patients [1,3,5,18]. As life expectancy 
worldwide especially in developing countries has experienced a steady growth and 
antiplatelet and anticoagulation therapy is widely available, incidence of chronic 
subdural hematoma is becoming an even more frequent diagnosis [1,3,5,18]. The 
recommended treatment of scSDH is surgery with burr hole trepanation, irrigation 
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and placement of a closed drainage system [19]. This procedure is safe, effective, 
technically easy and cost-efficient [19,20]. Widely used is the method described by 
Tabaddor and Shulman with burr hole craniostomy and placement of a subdural 
drainage system [16] and all newly established procedures have to prove their value 
as an alternative compared to this  method. In 2007, a study by Gazzeri et al was 
published about the treatment of scSDH with single burr hole craniostomy and 
placement of subgaleal closed drainage system instead of subdural closed drainage 
system showing lower rates of complications and recurrent hematoma than 
previously published series [4]. Recent studies by Taussky et al and Han et al 
pointed out that double burr hole craniotomy instead of single burr hole craniotomy 
shows favourable outcome and a lower rate of recurrent subdural hematoma [6,17]. 
Another randomized controlled study showed the positive effects of subdural 
drainage placement in operative treatment of scSDH [14]. In 2009 Zumofen et al 
published the first series of patients treated with placement of subperiostal drainage 
system instead of the widely used subdural drainage system after double burr hole 
craniotomy for hematoma evacuation [20]. This study showed equal to superior 
results compared to previous studies regarding hematoma recurrence, mortality and 
serious complications especially postoperative seizures. To further analyze the 
method of subperiostal drainage placement we compared this technique with the 
widely used procedure of subdural drainage placement for the treatment of scSDH 
for the first time in a single centre study. 
Patient characteristics, mean hematoma size, preoperative patient condition, 
antiplatelet and anticoagulation therapy, secondary diagnosis, preoperative 
symptoms and operative settings were comparable without significant differences 
between the two groups in this study. Patients in both groups were operated by the 
same surgeons and postoperative management took place at the same intensive 
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care unit and general ward and included the same postoperative management 
regarding removal of drainage, mobilisation, physiotherapy and medical treatment. 
Both methods proved being effective in the treatment of scSDH as in both groups 
mean hematoma size and preoperative symptoms dropped significantly after surgery. 
In accordance to the findings of Zumofen et al the rate of epileptic seizures dropped 
after surgery in the spd group5. However the differences were not statistically 
significant. In the sdd group operation had no effect on epileptic seizures during time 
of hospitalization. 
Overall surgical complications in both groups (8,5% spd group / 10,7% sdd group) 
were comparable to those previously published in the literature (4,6%-20,5%) [2,5,9-
11,13,20]. Medical complications could hardly be compared with previous 
publications as included diagnosis varied. The medical complication rates in the two 
groups of our study (43.8% spd group / 49,2% sdd group) were significantly higher as 
reported in previous publications about treatment of scSDH with burr hole craniotomy 
and placement of closed drainage systems [2,5,9,10,13,20]. However, in contrast to 
other publications, we included urinary tract infection, which accounted for around 
50% of medical complications in our study. 
 
We defined good outcome as reduction of preoperative symptoms and a low mortality 
and morbidity rate. Reduction of preoperative symptoms could be achieved 
significantly in both study groups as shown above. Overall mortality (2.1% spd group 
/ 10.7% sdd group) was slightly superior to previously published data (2.1-13.3%) 
[5,10,13,15,20] especially as we included all patients who died before follow up. 
General outcome (GOS 4.3 spd group / GOS 4.2 sdd group) was fairly good in the 
present study despite significant comorbidities and the high mean patient age (77 
years spd group / 71 years sdd group). Comparison of the outcome with previously 
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published studies turned out to be difficult, as time of evaluation and time of follow up 
as well as used outcome scales were non-uniform and results widely differed. 
Zumofen et al used comparable outcome scales at time of follow up and reported a 
comparable good outcome in 183 scSDH three month after surgery [20]. 
 
The two groups showed no significant differences regarding mean postoperative 
hematoma size and postoperative symptoms. Overall medical and surgical 
complications, outcome at discharge and at follow-up were comparable without 
significant differences although there was a tendency towards a lower rate of 
hematoma remnant and recurrence in the sdd group and a tendency towards lower 
rate of intraparenchymal hematoma and lower mortality in the spd group. 
The studies by Zumofen et al and Gazzeri et al indicate the advantages of placement 
of subperiostal closed drainage systems regarding rates of hematoma recurrence 
and serious complications [4,20]. This could especially been shown for elderly 
patients. For this reason we compared in a second step the study groups including 
only patients older than 80 years (25 with spd, 18 with sdd). We did not find different 
results in those subgroups. However the tendency towards lower mortality in the 
group treated with placement of subperiostal drainage was closer to significance 
(p=0.021). This effect has to be proven by means of follow up-studies with larger 
patient numbers. 
 
Overall we found no statistically significant differences regarding the preoperative 
condition and general data of the patients, the postoperative symptoms, the 
postoperative hematoma remnant, the rates of recurrent hematoma and mortality, the 
medical and surgical complications and the outcome at discharge and at three month 
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follow up between the groups treated with spd and sdd after double burr hole 
craniotomy and intraoperative irrigation. 
Nevertheless the results suggest that patients with predictable high risk of 
complications – especially older patients - can benefit from placement of a 
subperiostal drainage system instead of a subdural drainage system in surgery for 
scSDH due to the minor invasiveness of the surgical procedure, however accepting a 
slightly higher probability of hematoma recurrence. As the tendency for a lower rate 
of serious complications, a lower rate of mortality and a lower rate of postoperative 
epileptic seizures could not shown to be statistically significant in this study, further 
studies with higher numbers of patients and prospective study design need to be 
initiated. 
 
Conclusions: 
Our study shows for the first time a direct comparison of spd and sdd treatment in 
scSDH.  Both methods have proven to be highly effective in the treatment of cSDH. 
General patient data, complications, outcome and mortality of both investigated study 
groups are comparable or superior to previously published series. As there is a clear 
tendency to less mortality and less serious complications and despite a slightly higher 
rate of hematoma remnant or recurrence, the treatment with double burr hole 
trepanation, irrigation and placement of subperiostal drain is our treatment of choice 
in patients with predictable high risk of complications especially in patients older than 
80 years. 
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Legends: 
 
Figure 01: Postoperative CT scan after subperiostal drainage placement 
  A: Lateral view of high resolution 3D reconstruction 
  B: Medial view of high resolution 3D reconstruction 
 C: Axial view of soft tissue 
 D: Coronal view of soft tissue 
Figure 02: Postoperative CT scan after subdural drainage placement 
  A: Lateral view of high resolution 3D reconstruction 
  B: Medial view of high resolution 3D reconstruction 
 C: Axial view of soft tissue 
 D: Coronal view of soft tissue 
Table 01: Study and patients characteristics 
Table 02: Surgical characteristics and peri-/postoperative complications 
Table 03: Results regarding haematoma size and other neuroradiological findings 
Table 04: Results regarding pre-/postoperative symptoms and outcome 
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Abbreviations: 
cSDH chronic subdural hematoma 
scSDH symptomatic chronic subdural hematoma 
GCS Glasgow Coma Scale 
CT computed tomography 
GOS Glasgow Outcome Scale 
PACS picture archiving and communication system 
spd subperiostal drainage 
sdd subdural drainage 
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 Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
Number of patients 48 65 
Mean age in years (SD) 77 (±13) 71 (±13) 
Sex distribution, male 32 66.7% 45 69.2% 
Left side subdural haematoma  21 43.8% 14 21.5% 
Right side subdural haematoma 20 41.2% 28 43.1% 
Bilateral subdural haematoma 7 14.6% 23 35.5% 
Patients on  
  Oral anticoagulation medication 
  Antiplatelet medication 
 
11 
17 
 
22.9% 
35.4% 
 
18 
16 
 
27.7% 
24.6% 
Most frequent secondary diagnoses 
  Hypertension 
  Diabetes Mellitus II 
  Cardiac arrtythmia 
  Coronary disease 
  COPD 
  Chronic renal disease 
  History of malignant tumor 
  History of stroke 
 
23 
4 
8 
7 
2 
7 
9 
6 
 
47.9% 
8.3% 
16.7% 
14.6% 
4.2% 
14.6% 
18.7% 
12.5% 
 
29 
4 
10 
13 
4 
9 
9 
7 
 
44.6% 
6.1% 
15.4% 
20.0% 
6.1% 
13.8% 
13.8% 
10.7% 
 
SD = standard deviation, COPD = Chronic Obstructive Pulmonary Disease 
 
 Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
 p.Pat. 
n=48 
% p.Hae 
n=55 
% p.Pat. 
n=65 
% p.Hae 
n=88 
% 
Left side unilat. trepanation 
Right side unilateral trepanation 
Bilateral trepanation 
21 
20 
7 
43.8 
41.2 
14.6 
  14 
28 
23 
21.5 
43.1 
35.5 
  
Mortality during hospitalisation 
Mortality during follow up 
Overall mortality 
Mortality in patients > 80years 
0 
1 
1 
0 
0.0 
2.1 
2.1 
0.0 
0 
1 
1 
0 
0.0 
1.8 
1.8 
0.0 
1 
6 
7 
4 
1.5 
9.2 
10.7 
6.1 
1 
6 
7 
4 
1.1 
6.8 
7.9 
4.5 
Reoperations while hospitalised 
  Re-Evacuations 
  Craniotomies 
  Decompressive craniotomies 
Reoperations during follow up 
4 
3 
1 
0 
7 
8.3 
6.2 
2.1 
0.0 
14.5 
4 
3 
1 
0 
7 
7.3 
5.4 
1.8 
0.0 
12.7 
3 
2 
0 
1 
4 
4.6 
3.1 
0.0 
1.5 
6.1 
3 
2 
0 
1 
4 
3.4 
2.3 
0.0 
1.1 
4.5 
Overall complications 
  Clinical remnant 
  Recurrence of hematoma 
  Intracerebral hematoma 
  Urinary tract infection 
  Pneumonia 
  Wound infection 
  Other complications 
25 
3 
1 
0 
12 
3 
0 
6 
52.1 
6.2 
1.8 
0.0 
25.0 
6.2 
0.0 
12.5 
25 
3 
1 
0 
12 
3 
0 
6 
45.4 
5.4 
1.6 
0.0 
21.8 
5.4 
0.0 
10.9 
39 
1 
2 
4 
14 
9 
0 
9 
60.0 
1.5 
3.1 
6.1 
21.5 
13.8 
0.0 
13.8 
39 
1 
2 
4 
14 
9 
0 
9 
44.3 
1.1 
2.3 
4.5 
15.9 
10.2 
0.0 
10.2 
Surgical complications 
Medical complications 
4 
21 
8.3 
43.8 
4 
21 
7.3 
38.2 
7 
32 
10.7 
49.2 
7 
32 
7.9 
36.4 
 
p.Pat. = per patient, p.Hae = per hematoma 
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 Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
 preop postop follow up preop postop follow up 
Coronar width of hem 20.4±6.33 5.75±4.96 1.55±4.01 19.5±5.99 5.08±5.15 0.93±2.98 
Mean size of hem *103 119±57.2 8±15.4 6±20.7 108±48.3 8±11.9 2±10.3 
Hematomaremnant - 34/61.8% 8/14.5% - 49/55.7% 10/11.4% 
Mean midlineshift 7.37±3.97 3.65±2.82 - 6.90±4.96 3.03±2.78 - 
Postoperativ hygroma - - 12/33.3% - - 20/39.2% 
 
hem = hematoma, preop = preoperative, postop = postoperative  
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A: Preoperative Symptoms Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
 Pat. SD / % Pat. SD / % 
Mean GCS at admission 
  GCS 13-15 
  GCS 9-12 
  GCS 3-8 
14.2 
43 
4 
1 
1.56 
89.6% 
8.3% 
2.1% 
14.2 
61 
3 
1 
1.78 
93.8% 
4.6% 
1.5% 
Symptoms at admission 
  Paresis 
  Aphasia 
  Headache 
  Imbalance 
  Epileptic seizures 
  Acute state of confusion 
 
25 
11 
30 
39 
6 
28 
 
52.1% 
22.9% 
62.5% 
81.3% 
12.5% 
58.3% 
 
34 
21 
44 
33 
4 
31 
 
52.3% 
32.3% 
67.7% 
50.8% 
6.2% 
47.7% 
 
B: Postoperative Symptoms and outcome Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
 Pat. SD / % Pat. SD / % 
Mean hospitalisation (days) 9.6 5.30 9.1 5.77 
Postoperative CT within 12h 
Postoperative CT within 24h 
20 
46 
41.7% 
95.8% 
20 
62 
30.7% 
95.4% 
Mean GOS at discharge 
  GOS 5 
  GOS 4 
  GOS 3 
  GOS 2 
  GOS 1 
4.3 
18 
28 
2 
0 
0 
0.55 
37.5% 
58.3% 
4.2% 
0.0% 
0.0% 
4.2 
26 
28 
10 
0 
1 
0.81 
40.0% 
43.1% 
15.4% 
0.0% 
1.5% 
Symptoms at discharge 
  Paresis 
  Aphasia 
  Headache 
  Imbalance 
  Epileptic seizures 
  Acute state of confusion 
 
5 
2 
6 
21 
1 
9 
 
10.4% 
4.2% 
12.5% 
43.8% 
2.1% 
18.8% 
 
9 
7 
15 
16 
4 
10 
 
13.8% 
10.8% 
23.1% 
24.6% 
6.2% 
15.4% 
 
C: Symptoms at follow up and long term 
outcome 
Trepanation and 
subperiostal drain 
Trepanation and 
subdural drain 
 Pat. SD / % Pat. SD / % 
Mean follow up after (days) 
Loss to follow up 
68 
8 
34 
16.6% 
90 
14 
48 
21.5% 
Mean GOS at follow up 
  GOS 5 
  GOS 4 
  GOS 3 
  GOS 2 
  GOS 1 
4.8 
30 
6 
0 
0 
0 
0.40 
83.3% 
16.6% 
0.0% 
0.0% 
0.0% 
4.8 
41 
9 
1 
0 
0 
0.46 
80.4% 
17.6% 
1.9% 
0.0% 
0.0% 
Persisting hematoma remnant 8 22.2% 10 19.6% 
Mortality during follow up 1 2.1% 6 10.5% 
Persisting hematoma related symptoms 6 16.7% 9 17.6% 
Overall Reoperation 11 20.0% 6 6.8% 
 
GCS = Glasgow Coma Scale, Pat. = number of patients, SD = standard deviation, CT = computed 
tomography, GOS = Glasgow Outcome Scale 
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